Cue Health Reports Third Quarter 2022 Results
SAN DIEGO–(BUSINESS WIRE)–Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the third quarter of 2022. Recent Highlights Revenue of $69.6 million in the third quarter of 2022, exceeding guidance Flu A/B molecular test de novo submission to the U.S. Food and Drug Administration (FDA) for full clearance for … [Read more…]